Showing posts with label patent litigation. Show all posts
Showing posts with label patent litigation. Show all posts

Friday, 5 August 2016

Subsidized IP Litigation Insurance in Japan and Increased Enforcement in China

As reported by Ellie Wilson on the IP Kat blog, the Japanese Patent Office (JPO) has announced a program whereby half of the premiums for IP infringement insurance will be covered.  The program is a partnership between the JPO, the Japan Chamber of Commerce and Industry, The National Federation of Small Business Associations, and three insurance companies.  Specifically, the subsidy is directed at making affordable IP infringement litigation insurance for SMEs that are operating in countries outside of Japan. The announcement appears to cover both the need for the SME to fund IP infringement litigation against alleged infringers and to defend litigation.  Notably, the announcement explicitly mentions China as a market of concern; although my guess is that a concern with so-called patent trolls in the United States is also an issue. 

This announcement comes close in time to reports of increased enforcement of intellectual property rights in China, particularly as China reportedly is attempting to move toward an innovation and services based economy.  Interestingly, the official website for The Supreme People's Court of the People's Republic of China published an article by Ma Si (China Daily) concerning the move of smart phone wars to China titled, "Chances high for more patent cases."  The article discusses the recent stayed injunction against Apple and the prospects for more patent cases given actions in the United States concerning Huawei.  Huawei and Samsung are also embroiled in litigation in China.

Given the importance of SMEs to economic growth and job creation as well as the general high cost of litigation, it will be interesting to see if more countries move to subsidize IP litigation insurance.  Are there any other countries subsidizing IP litigation insurance?  Instead of regulating against so-called patent trolls, is this where government should intervene--helping insurance markets develop and lowering the cost of insurance, particularly for SMEs?  Should government back insurance funds for IP litigation?    

Saturday, 20 July 2013

Myriad—Enforcement Continues and Now March-in Rights to Protect the Public?

Immediately after the U.S. Supreme Court issued the Myriad opinion, numerous competitors to Myriad announced that they would offer genetic testing for breast cancer at a much lower price than that offered by Myriad before the decision.  One of those competitors was Gene by Gene who offered the possibly noninfringing test for a price that was about one third of Myriad’s price before the U.S. Supreme Court’s decision.  Myriad responded with several patent infringement suits alleging infringement against some competitors including Gene by Gene.  Here is the Gene by Gene complaint filed on July 10, 2013. 

Notably, some of the patents held by Myriad were funded by the federal government and thus, are subject to the provisions of the Bayh-Dole Act.  The influential U.S. Senator Patrick Leahy of Vermont has sent a letter to the Director of the National Institutes of Health urging the exercise of “march-in rights” under the Bayh-Dole Act.  March in rights can be exercised by the federal government in certain circumstances:

(a) With respect to any subject invention in which a small business firm or nonprofit organization has acquired title under this chapter, the Federal agency under whose funding agreement the subject invention was made shall have the right, in accordance with such procedures as are provided in regulations promulgated hereunder to require the contractor, an assignee or exclusive licensee of a subject invention to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants, upon terms that are reasonable under the circumstances, and if the contractor, assignee, or exclusive licensee refuses such request, to grant such a license itself, if the Federal agency determines that such--

(1) action is necessary because the contractor or assignee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the subject invention in such field of use;

(2) action is necessary to alleviate health or safety needs which are not reasonably satisfied by the contractor, assignee, or their licensees; . . . .

March in rights have never been exercised by the federal government even though there have been several requests.  What good are the rights if they are never exercised?  As a deterrent?  How good is the deterrent if the rights aren’t going to be exercised?  The prior requests have mostly involved claims concerning reasonable pricing—a theory which has been rejected by some.  Is this the perfect case for a change (at least for federally funded patents)?  Can Myriad price its tests in such a way that allows it to recover its alleged $500 million in developing the patented inventions, earn a “reasonable” profit and provide relatively wide access? What do you think? 

Tuesday, 16 July 2013

A Great Story about Patent Trolls or How to Make an Offer You Can't Refuse

The NY Times published a fantastic (and very troubling) piece, How a Typical Patent Battle Took an Unexpected Turn, about a start-up and its fight with a “patent troll” with some great twists.  I experienced a wide range of emotions in reading this article and the story will continue to evolve.  Here is the article.  Who are the winners (if any)?  Who are the losers (if any)?  I hope the "trolls" don't start colluding--protection anyone?  What do you think? 

Wednesday, 16 June 2010

Rambus shares nosedive on court news

#alttext#It's been rather interesting to follow Rambus stock market fortunes over the past few months (a chart is available over at Yahoo Finance here). Much of the movement over the past few weeks has been based on IP related issues.

We've already reported here earlier issues surrounding Rambus numerous disputes. Rambus has now received a further setback in its various legal cases, as reported by Reuters.

#alttext#It must be very frustrating for Rambus that the latest delay in resolving their case against Hynix and Micron relates to the retirement of a Federal judge in May of this year, just before a decision was due to be issued in the Appeal procedure about whether Rambus destroyed key documents. Instead of a decision relating to damages payable to Rambus, the court ordered a rehearing in October of this year. The continued uncertainty about whether will be entitled to damages certainly does not help confidence in the company whose share price dropped from USD 21.90 to USD 18.19 on the decision.#alttext#

The case really highlights the impact that decisions in IP matters have on the value of a company - as measured by the stock price. If Rambus win the case then their business will be backed by a solid base of patent rights and their revenues buoyed up by licence income. Should they lose, then much of their business model could be destroyed. The short term nature of the stock markets does not match with the current leisurely pace of the courts in deciding matters that can effect the long term health of a company. Rambus is probably healthy enough to survive and has had success in other cases not tainted by allegations of deliberate destruction of documents. There are other companies whose fate is decided in court after months of uncertainty.

It's not surprising that Reuters reported that the Rambus CEO spends much of his time dealing with lawyers. Apparently the company spent half of its 2009 USD 115 Million of revenues on legal fees (adding to its corporate running total to its lawyers since founding of USD 300 Million.

Technorati Tags:
, ,



Wednesday, 31 December 2008

Patent Litigation, the ITC, and Hardship in the Chip Industry

One of the verities of IP law and practice is "Wilkof's Law". For those of you (probably all of you) who have never heard of "Wilkof"s Law", it goes like this. Question: "How do you know when there is economic slowdown?" Answer: "There is an increase in patent litigation."

A clear example of this principle was described recently on Bloomberg.com (23cDecember 23) under the title--"Chipmakers Hire Armies of Lawyers to Boost Revenues Amid Slump." The report described the efforts of chip (of the computer and not the confectionery kind) manufacturers to make increasing use of patent litigators to try and make up for the expected severe downfall in profits for the industry during 2009. The anticipated drop in revenue for 2009 is indeed grim. According to the report, 2008 witnessed a 4.4% decline in sales, and a 16% crater-like decline in sales in forecast for 2009. Never has the industry experienced back-to-back declines in overall annual sales.

The list of current and possible patent litigation activity is broadly based in the industry. Thus it is reported that Qimonda, LSI and Spansion have all brought patent infringement actions before the ITC. Such actions tend to take much less time than a court action, and they may lead to a settlement with payment made into the patentee's coffers. Particularly notable is Spansion, which is reported to have not recorded a profit since going public in 2005. Licensing fees from defendants is one way to remedy this situation, if only in part.

When licensing fails, going forward with the suit is always a possibility. In one such high profile court filing, Spansion has recently sued Samsung for patent infringement in the area of flash memory chips. As well, Qimonda is reported to crossing patent swords with Seagate Technology, and LSI has commenced patent litigation matter with Freescale Semiconductor and Elpida Memory.

The pros and cons of bringing an ITC action with the intention of reaching a licensing arrangement were described by Robert Krupka of Kirkland & Ellis as follows. On the one hand, an ITC proceeding might actually be more expensive than a regular court proceeding (this is due to the procedural requirements of such action), with costs in the area of $5 million or more. On the other hand, for the target, settlement might be the better part of valor, especially since such an arrangement ensures the target's continuing right to sell in the U.S. market. It would seem that there is a bit of the patent-troll mind-set in all of this, although I suspect that none of the plaintiffs to such an action would so characterize themselves.

Your friendly patent trolls in action

In considering this expected flurry of chip-related patent litigation during 2009, we bring you the following comment from from the Bloomberg article. As noted, "Jerry Sanders, the founder of AMD, used to say, "Real Men own fabs", said Craig Berger.... That's kind of changed. Now it's, "Real men have huge armies of lawyers."

Or, stated otherwise, Wilkof's law is alive and well.


"Real men own fabs"--that is so yesterday ...

Monday, 13 October 2008

Cutting the cost of patent litigation: streamlining and cost-capping

The cost of litigating patents is an issue that rarely fades from the IP owner's consciousness for long, and it has been pointed on many occasions that a judicial dispute resolution mechanism that is too expensive for users of the patent system can have the effect of rendering that system functionally useless. In the article below, English IP practitioner Chris Ryan (right) outlines his thoughts on the cost of patent litigation and cost-capping. If you'd like to comment on what he has said, you can email him directly here or post a comment below. Chris writes:

"In the October issue of the CIPA Journal I have suggested that some of the criticism of the cost of IP litigation in the UK courts could be avoided if the Patents County Court adopted procedures that were much simpler than those applied in the High Court. The little-used streamline procedure should become the norm and the suitability of a case for determination by that method should be the determining factor as to which court it should be allocated to. I suggested that the combination of streamlined procedure and a cost capping order (again to be regarded as the norm) could create a distinct regime; one that might result in the justice dispensed by the court being a little less dependable, but that would certainly provide a significantly cheaper alternative to the High Court. I was encouraged to include costs capping in my suggestion by the publication of the new edition of the Patents Court and Patents County Court Guide here, which I noticed mentioned costs-capping as an available case management technique.

Now the Civil Procedure Rule Committee has published proposals here for clarifying uncertainty about the legitimacy and appropriate use of costs capping orders in all types of litigation. They are open for consultation until 24 October. However, the Committee suggests (in proposed amendments to CPR 44.18) that the only criteria to be applied should be ones arising from the nature of the particular case under consideration (interests of justice, financial state of the parties, normal case management procedures ineffective etc), not the nature of the forum in which it is to be determined. It seems to me that the new rules would undermine my proposal because the applicable criteria will have to be (expensively) assessed in each case. I would like to see them supplemented by a rule that says that the other criteria may, in effect, be “trumped” by the fact that the case has been brought in, or transferred to, a special court originally created for the express purpose of providing a low cost alternative to the High Court. I wonder if others agree:

(a) that a distinct, and distinctly cheaper regime in the PCC makes sense; and
(b) that this can be achieve by the universal application of the existing rules on streamlining and costs capping.

And if anyone is with me this far would they like to contribute a suggested form of words for a rule which would have that effect?"